Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT)

Historical Holders from Q3 2016 to Q3 2025

Symbol: FLGT on Nasdaq
Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 30,210,911
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 17,228,107
Holdings value: $389,318,961
% of all portfolios: 0.001%
Number of holders: 162
Number of buys: 73
Number of sells: -75
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BARCLAYS PLC	7.57%	+43%	$42,396,117	+$12,335,507	2,338,451	+41%	Barclays PLC	31 Mar 2025
BlackRock, Inc.	5.9%		$32,993,391		1,819,823		BlackRock, Inc.	31 Mar 2025
MILLENNIUM MANAGEMENT LLC	5.6%	+18%	$33,633,203	+$4,961,034	1,691,811	+17.3%	Millennium Management LLC	22 Jul 2025

Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	17,228,107	$389,318,961	+$21,532,521	$0	$3,373,080	$22.6	162
2025 Q2	16,260,263	$323,227,753	+$1,152,439	$493,024	$3,683,764	$19.88	165
2025 Q1	16,317,307	$275,768,406	-$14,217,098	$894,010	$6,406,790	$16.9	173
2024 Q4	17,016,195	$314,285,279	+$12,985,883	$884,713	$43,500,544	$18.47	185
2024 Q3	16,092,056	$349,642,907	+$18,556,959	$304,220	$44,259,664	$21.73	181
2024 Q2	15,271,785	$299,655,107	+$9,367,412	$547,398	$20,958,084	$19.62	170
2024 Q1	14,727,786	$319,564,135	+$6,539,138	$2,015,930	$25,226,250	$21.7	177
2023 Q4	14,302,809	$413,495,913	+$4,547,542	$3,434,508	$37,921,247	$28.91	193
2023 Q3	14,229,204	$380,479,266	+$6,537,668	$4,331,880	$17,498,656	$26.74	196
2023 Q2	13,900,018	$514,629,091	+$13,570,378	$5,076,813	$5,839,631	$37.03	210
2023 Q1	13,537,003	$422,618,519	+$14,324,645	$4,673,634	$6,036,406	$31.22	213
2022 Q4	13,130,080	$391,069,830	-$9,588,373	$6,634,678	$8,561,346	$29.78	218
2022 Q3	13,298,290	$506,859,271	-$7,820,533	$11,817,000	$16,755,000	$38.12	217
2022 Q2	12,997,411	$708,963,224	+$53,955,153	$34,985,950	$42,941,078	$54.53	247
2022 Q1	12,047,292	$751,600,750	+$40,161,746	$42,524,000	$45,265,000	$62.41	263
2021 Q4	11,205,792	$1,127,293,672	-$26,292,784	$58,914,384	$52,581,349	$100.59	284
2021 Q3	11,367,430	$1,022,253,660	+$64,809,061	$57,668,150	$59,195,345	$89.95	258
2021 Q2	10,632,791	$980,578,944	+$54,311,867	$94,964,097	$95,991,909	$92.23	246
2021 Q1	10,008,047	$966,031,706	+$64,885,192	$119,395,000	$88,577,000	$96.62	243
2020 Q4	9,615,937	$501,565,082	+$82,198,208	$47,413,000	$30,380,000	$52.1	184
2020 Q3	8,084,326	$323,850,761	+$79,786,110	$4,909,000	$7,559,000	$40.04	122
2020 Q2	6,322,946	$101,163,272	+$14,541,369			$16	81
2020 Q1	6,111,180	$65,545,855	+$3,544,598			$10.76	72
2019 Q4	5,668,534	$73,105,675	+$35,387,759			$12.9	70
2019 Q3	2,927,084	$30,408,049	+$16,888,791			$10.39	33
2019 Q2	1,301,144	$8,691,007	+$411,415			$6.68	12
2019 Q1	1,242,460	$7,393,006	+$220,569			$5.95	15
2018 Q4	1,210,059	$3,835,003	-$982,557			$3.17	13
2018 Q3	1,458,250	$5,731,004	+$22,470			$3.93	15
2018 Q2	1,452,436	$6,013,004	+$11,608			$4.14	15
2018 Q1	1,449,767	$5,789,004	+$112,502			$3.99	18
2017 Q4	1,415,208	$6,199,004	-$6,549,628			$4.38	16
2017 Q3	2,390,312	$11,378,005	-$4,107,706			$4.79	19
2017 Q2	2,976,441	$19,019,006	-$5,819,346			$6.39	20
2017 Q1	3,492,074	$38,134,153	+$4,840,117			$10.92	35
2016 Q4	3,066,506	$35,477,491	+$5,733,496			$11.57	36
2016 Q3	2,647,726	$24,413,000	+$24,413,000			$9.22	16